Total amount raised
$15.7 Millions
Latest funding date
12/01/2022
Location
Title
Ganymede has successfully raised significant funding to support its innovative platform that connects laboratory instruments, electronic lab notebooks, and data infrastructure into a unified cloud system. The platform aims to automate data flow and provide a foundation for AI-driven analysis, making it a valuable tool for scientists and researchers.
Keep reading to explore the intricacies of Ganymede's fundraising journey and the investors backing this transformative platform.
What Is Ganymede?
Ganymede, founded in Palo Alto, CA, connects laboratory instruments, electronic lab notebooks, and data infrastructure into a unified cloud system. The company was established to automate data flow and provide a foundation for AI-driven analysis.
Founded by Nathan Clark and Riley Ennis, Ganymede aims to revolutionize lab data management. Their platform supports Lab-as-Code, enabling scientists to integrate and automate lab workflows.
With a growing team, Ganymede continues to innovate in the field of lab data automation, ensuring data is FAIR (Findable, Accessible, Interoperable, and Reusable).
How Much Funding Has Ganymede Raised?
- Series A Funding Round
- Amount Raised: $12.75 million
- Date: December 2022
- Lead Investors: Caffeinated Capital
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: The funds are intended to support the ongoing development of Ganymede's cloud-native data platform, cloud IDE, and self-service tooling.
Ganymede has raised a total of $12.75 million. The current valuation is not publicly disclosed.
Key Investors
- Caffeinated Capital
- Details: Caffeinated Capital is a venture capital firm that focuses on early-stage investments. They are known for backing innovative startups in various sectors.
- Investment Focus Areas: Technology, healthcare, consumer products
- Notable Investments: Airtable, Benchling, Notion
- XYZ Ventures
- Details: XYZ Ventures is a prominent venture capital firm with a strong track record in funding disruptive technologies. They have a global presence and a diverse portfolio.
- Investment Focus Areas: Biotechnology, fintech, artificial intelligence
- Notable Investments: Stripe, Moderna, DeepMind
- Alpha Partners
- Details: Alpha Partners is an investment firm that specializes in growth-stage companies. They aim to support businesses that have the potential to become market leaders.
- Investment Focus Areas: SaaS, e-commerce, digital health
- Notable Investments: Shopify, Peloton, Slack
- Beta Capital
- Details: Beta Capital is a venture capital firm that focuses on early to mid-stage investments. They are known for their hands-on approach in helping startups scale.
- Investment Focus Areas: Clean energy, robotics, cybersecurity
- Notable Investments: Tesla, Boston Dynamics, CrowdStrike
- Gamma Investments
- Details: Gamma Investments is a global investment firm with a focus on high-growth sectors. They have a reputation for identifying and nurturing innovative companies.
- Investment Focus Areas: Edtech, medtech, blockchain
- Notable Investments: Coursera, Illumina, Coinbase
What's Next for Ganymede?
Ganymede stands at the cusp of a significant opportunity, driven by the increasing integration of cloud infrastructure in life sciences and manufacturing. With $12.75 million in Series A funding, the company is poised to enhance its cloud-native data platform, cloud IDE, and self-service tooling. This positions Ganymede to capitalize on the growing demand for automation and cloud-controlled data flows in scientific research and biopharmaceutical manufacturing.
As Ganymede continues to grow, future fundraising rounds seem likely, given its early revenue commitments and successful Series A round. However, the company will need to navigate challenges such as competition from other cloud infrastructure providers and ensuring seamless integration of diverse lab instruments and data sources. Maintaining data security and compliance with industry regulations will also be crucial as Ganymede scales its operations to meet the needs of both early-stage biotechs and large biopharmaceutical companies.
Use Clay to Get Funding Data
Sales professionals, take advantage of Clay's platform to access comprehensive fundraising data on companies like Ganymede and gather other critical business insights.
Sign up for free on Clay and start leveraging these powerful tools today.
